Paris, 17 may 2017 – France Biotech, the association of entrepreneurs in biotechnology and the life sciences (www.france-biotech.org), which publishes each year its Panorama of the industry, a study focused on innovative companies in Life Sciences, will present the restitution of the study over the course of a “What’s up” , an event the pole Atlanpole Biotherapies, the CCO Nantes, the opportunity to discover the major trends in the sector for this year.
Download the free guide
Boost your gains
“We are thrilled to come and present our Panorama annual Life Sciences in Nantes, metropolis leader at the forefront of the digital industry and health care in France”, including entrepreneurship in the life sciences is very dynamic. The mission of France Biotech is to promote the life sciences in a broad sense, but especially to promote the environment, whether it is financial, tax, regulatory, cultural, ethical, and entrepreneurial spirit to engage in new partnerships, both in France and internationally. This event is a great platform of visibility for the industry and a barometer of success achieved by the biotechnology industry in France and the trends that define this year, ” said Maryvonne Hiance, president of France Biotech and vice-president of Atlanpole Biotherapies.
Four interventions are on the program of this event open to the press :
Introduction by Maryvonne Hiance, President of France Biotech
Review of the activities of biotechs and medtechs by Chloe Evans, project manager, France Biotech
The financing of companies by the markets : Frédéric Boiffin, responsible for West region, Enternext
Gwenaël Chedaleux, partner at KPMG, will present the mergers and acquisitions on the market
This presentation will be followed by a cocktail reception from 18: 30 to 20h, to continue the exchange.
You can access the detailed program of the event by clicking on the following link : PROGRAM
Registration for this event is required and may be made at the following address : https://www.eventbrite.fr/e/billets-whats-up-en-partenariat-avec-france-biotech-32884046067
Please confirm your attendance with ALIZE RP.
About France Biotech
Created in 1997, France Biotech is the French institution that brings together the main companies in the life sciences and its expert partners. France Biotech has for mission to accompany the development of this industry in France on land the legislative and fiscal environment. The origin of the status of Young Innovative Enterprise (JEI) established in the Finance Act of 2004, France Biotech advocates for the innovative sector represents an industry high performance a?? full. France Biotech is chaired by Maryvonne Hiance and has more than 150 members and a board of directors from representatives of 20 innovative companies in the health sector.
About Atlanpole Biotherapies
Atlanpole Biotherapies is a French competitiveness cluster inter-regional Country of the Loire – Bretagne – Centre Val de Loire, accredited by the Ministry of Industry (July 2005). Atlanpole Biotherapies, brings together the expertise of over 170 members (laboratories, platforms and businesses) who are involved in the value chain of bio-medicine from target discovery up to clinical evaluation.
The pole is involved in the construction of the medicine of tomorrow around 4 axes :
– Immunotherapy
– Radiopharmaceuticals
– Regenerative medicine
– Innovative technologies for biotherapies
Download the free guide
Boost your gains
